Skip to main content

MoneyWorks4Me

Cadila Healthcare informs about press release

06 Sep 2021 Evaluate

Cadila Healthcare has informed that it enclosed a copy of press release dated September 6, 2021 titled ‘Zydus Cadila’s Sitagliptin base tablets receives Tentative Approval from FDA’.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1940.00
Dr. Reddys Labs. 1389.00
Cipla 1418.95
Lupin 2030.30
Zydus Lifesciences 1228.65
View more..